# Jean-Jacques Grob

Source: https://onco.cc/people/jean-jacques-grob/  
OnCo record `jean-jacques-grob` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Marseille dermatologist who led KEYNOTE-629, which established pembrolizumab for advanced cutaneous squamous-cell carcinoma, and who has been a senior investigator on many European melanoma trials.

## Summary

Jean-Jacques Grob is professor of dermatology at Aix-Marseille University and a leader of the French and European melanoma trial groups. He was first author of the 2020 Journal of Clinical Oncology report of KEYNOTE-629, in which pembrolizumab produced durable responses in recurrent or metastatic cutaneous squamous-cell carcinoma, and a lead investigator on the COMBI-d, KEYNOTE-054 and CheckMate 238 melanoma trials.

## Fields

- Kind: Person
- Last checked: 2026-09-18
- Tags: skin; melanoma; immunotherapy; trialist
- Role: Professor of Dermatology, Aix-Marseille University, Hôpital de la Timone
- Specialisms: Melanoma; Cutaneous squamous-cell carcinoma; Adjuvant immunotherapy

## Connected records

- cancers: [Advanced cutaneous squamous cell carcinoma](https://onco.cc/cancers/advanced-cutaneous-scc/), [Melanoma](https://onco.cc/cancers/melanoma/), [Skin cancer (all types)](https://onco.cc/cancers/skin-cancer/)
- institutions: [Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille](https://onco.cc/institutions/ap-hm-timone/)
- key papers: [KEYNOTE-629: pembrolizumab monotherapy for recurrent or metastatic cutaneous squamous cell carcinoma](https://onco.cc/key-papers/paper-keynote-629-pembrolizumab-cscc-grob-jco-2020/)

---
JSON: https://onco.cc/api/v1/entities/jean-jacques-grob.json